Cunningham K A, Callahan P M, Appel J B
Eur J Pharmacol. 1985 Jan 22;108(2):179-86. doi: 10.1016/0014-2999(85)90723-x.
The stimulus properties of the serotonin precursor 1-5-hydroxytryptophan (5-HTP) and the hallucinogen d-lysergic acid diethylamide (LSD) were compared in a two-lever, water-reinforced drug discrimination task. 5-HTP (in combination with the peripheral decarboxylase inhibitor Ro 4-4602) elicited no more than 50% drug-lever responding in rats trained to discriminate LSD (0.08 mg/kg) from saline while LSD substituted completely in animals trained to discriminate 5-HTP (50 mg/kg) from saline. Combination tests indicated that, while the 5-HTP cue was unaffected by pretreatment with various serotonin antagonists, the substitution of LSD for 5-HTP was abolished by the putative serotonin-2 antagonist ketanserin. It was concluded that LSD mimics 5-HTP by stimulating a subset of serotonin receptors activated by 5-HTP which are sensitive to ketanserin (serotonin-2?).
在一项双杠杆、水强化的药物辨别任务中,比较了血清素前体1-5-羟色氨酸(5-HTP)和致幻剂d-麦角酸二乙酰胺(LSD)的刺激特性。在训练大鼠区分LSD(0.08毫克/千克)和生理盐水的实验中,5-HTP(与外周脱羧酶抑制剂Ro 4-4602联合使用)引发的药物杠杆反应不超过50%,而在训练大鼠区分5-HTP(50毫克/千克)和生理盐水的实验中,LSD能完全替代5-HTP。联合试验表明,虽然5-HTP线索不受各种血清素拮抗剂预处理的影响,但假定的血清素-2拮抗剂酮色林可消除LSD对5-HTP的替代作用。得出的结论是,LSD通过刺激5-HTP激活的对酮色林敏感的血清素受体子集(血清素-2?)来模拟5-HTP。